tiprankstipranks

Uli Hacksell Insider Profile

4 Followers
Uli Hacksell, CEO, Director at ACADIA Pharmaceuticals, holds 20.00K shares in Avalo Therapeutics (Ticker: AVTX), holds 145.55K shares in ACADIA Pharmaceuticals (Ticker: ACAD), holds ― shares in Cerecor Inc (Ticker: CERCU).
tipranks
Uli Hacksell

Uli Hacksell
ACADIA Pharmaceuticals (ACAD)
CEO, Director

Ranked #1,982 out of 98,909 Corporate Insiders

Profitable Transactions

83%
10 out of 12 Profitable Transactions

Average Return

+43.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
91.37%
8.63%
0.00%
A breakdown of Uli Hacksell's holdings

Insider Roles

ACADIA Pharmaceuticals
(ACAD)
CEO, Director
Avalo Therapeutics
(AVTX)
Director
Cerecor Inc
(CERCU)
CEO & President, Director
Roles that Uli Hacksell holds in companies

Most Profitable Insider Trade

Stock:
ACADIA Pharmaceuticals
(ACAD)
Rating:Informative Buy
Date:Jul 16, 2014 - Jul 16, 2015
Return:+146.80%
The most profitable trade made by Uli Hacksell

Uli Hacksell's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ACADIA Pharmaceuticals
Feb 19, 2015
CEO, Director
Informative Buy
46.50K
$2.20M
Avalo Therapeutics
Apr 01, 2019
Director
Uninformative Buy
14.90K
$207.80K
Cerecor Inc
CEO & President, Director
List of latest transactions for each holding click on a transaction to see Uli Hacksell's performance on stock

Uli Hacksell insider profile FAQ

What is the percentage of profitable transactions made by Uli Hacksell?
The percentage of profitable transactions made by Uli Hacksell is 83%.
    What is the average return per transaction made by Uli Hacksell?
    The average return per transaction made by Uli Hacksell is 43.60%.
      What stocks does Uli Hacksell hold?
      Uli Hacksell holds: ACAD, AVTX, CERCU stocks.
        What was Uli Hacksell’s latest transaction?
        Uli Hacksell latest transaction was an Uninformative Buy of $14.90K.
          What was Uli Hacksell's most profitable transaction?
          Uli Hacksell’s most profitable transaction was an Informative Buy of ACAD stock on July 16, 2014. The return on the trade was 146.80%.
            What is Uli Hacksell's role in ACADIA Pharmaceuticals?
            Uli Hacksell's role in ACADIA Pharmaceuticals is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.